Piton Capital

With a global mission to “make the healthcare experience more human”, Docplanner creates digital apps and software solutions for doctors, clinics, hospitals and patients to enable the healthcare ecosystem and the patient journey to work together more seamlessly. With free doctor reviews and instant online appointment booking for patients through its online marketplaces, Docplanner has a network of almost 2 million healthcare professionals, serves over 260,000 customers globally with over 22m patient appointments booked per month, and operates in 13 countries across Europe and LATAM. Doctors and clinics count on Docplanner to facilitate scheduling, booking, communication and payments for millions of patients a month. Through its innovative and user-friendly software, doctors and clinics can optimize patient flows, reduce costly no-shows and completely digitize their practices - all resulting in valuable time savings that can instead be used to improve patient outcomes and experiences. Via its TuoTempo brand, the company offers a more sophisticated suite of optimisation products for large healthcare institutions. Docplanner was founded in 2012 in Poland and now boasts a team of more than 2,800 based across offices in Warsaw, Barcelona, Istanbul, Rome, Mexico City, Munich, Berlin, Rio, Curitiba, Bologna and our Amsterdam headquarter. It is backed by leading venture capital funds, including Point Nine Capital, Goldman Sachs Private Capital and One Peak Partners, raising a total of approximately €400 million to date.

With a global mission to “make the healthcare experience more human”, Docplanner creates digital apps and software solutions for doctors, clinics, hospitals and patients to enable the healthcare ecosystem and the patient journey to work together more seamlessly. With free doctor reviews and instant online appointment booking for patients through its online marketplaces, Docplanner has a network of almost 2 million healthcare professionals, serves over 260,000 customers globally with over 22m patient appointments booked per month, and operates in 13 countries across Europe and LATAM. Doctors and clinics count on Docplanner to facilitate scheduling, booking, communication and payments for millions of patients a month. Through its innovative and user-friendly software, doctors and clinics can optimize patient flows, reduce costly no-shows and completely digitize their practices - all resulting in valuable time savings that can instead be used to improve patient outcomes and experiences. Via its TuoTempo brand, the company offers a more sophisticated suite of optimisation products for large healthcare institutions. Docplanner was founded in 2012 in Poland and now boasts a team of more than 2,800 based across offices in Warsaw, Barcelona, Istanbul, Rome, Mexico City, Munich, Berlin, Rio, Curitiba, Bologna and our Amsterdam headquarter. It is backed by leading venture capital funds, including Point Nine Capital, Goldman Sachs Private Capital and One Peak Partners, raising a total of approximately €400 million to date.

With a global mission to “make the healthcare experience more human”, Docplanner creates digital apps and software solutions for doctors, clinics, hospitals and patients to enable the healthcare ecosystem and the patient journey to work together more seamlessly. With free doctor reviews and instant online appointment booking for patients through its online marketplaces, Docplanner has a network of almost 2 million healthcare professionals, serves over 260,000 customers globally with over 22m patient appointments booked per month, and operates in 13 countries across Europe and LATAM. Doctors and clinics count on Docplanner to facilitate scheduling, booking, communication and payments for millions of patients a month. Through its innovative and user-friendly software, doctors and clinics can optimize patient flows, reduce costly no-shows and completely digitize their practices - all resulting in valuable time savings that can instead be used to improve patient outcomes and experiences. Via its TuoTempo brand, the company offers a more sophisticated suite of optimisation products for large healthcare institutions. Docplanner was founded in 2012 in Poland and now boasts a team of more than 2,800 based across offices in Warsaw, Barcelona, Istanbul, Rome, Mexico City, Munich, Berlin, Rio, Curitiba, Bologna and our Amsterdam headquarter. It is backed by leading venture capital funds, including Point Nine Capital, Goldman Sachs Private Capital and One Peak Partners, raising a total of approximately €400 million to date.

With a global mission to “make the healthcare experience more human”, Docplanner creates digital apps and software solutions for doctors, clinics, hospitals and patients to enable the healthcare ecosystem and the patient journey to work together more seamlessly. With free doctor reviews and instant online appointment booking for patients through its online marketplaces, Docplanner has a network of almost 2 million healthcare professionals, serves over 260,000 customers globally with over 22m patient appointments booked per month, and operates in 13 countries across Europe and LATAM. Doctors and clinics count on Docplanner to facilitate scheduling, booking, communication and payments for millions of patients a month. Through its innovative and user-friendly software, doctors and clinics can optimize patient flows, reduce costly no-shows and completely digitize their practices - all resulting in valuable time savings that can instead be used to improve patient outcomes and experiences. Via its TuoTempo brand, the company offers a more sophisticated suite of optimisation products for large healthcare institutions. Docplanner was founded in 2012 in Poland and now boasts a team of more than 2,800 based across offices in Warsaw, Barcelona, Istanbul, Rome, Mexico City, Munich, Berlin, Rio, Curitiba, Bologna and our Amsterdam headquarter. It is backed by leading venture capital funds, including Point Nine Capital, Goldman Sachs Private Capital and One Peak Partners, raising a total of approximately €400 million to date.